
Work Here?
BGBx is a healthcare consultancy that helps pharmaceutical, biotech, and medical device companies turn scientific advances into practical, credible brand stories and strategies. Its services include medical communications to explain science clearly, market access planning to help products reach patients, and payer strategy to work with insurance decision-makers. The work is done by a team that combines clinical knowledge, academic insight, and industry experience, and is delivered through project-based engagements that aim for real-time, real-world impact. Unlike firms that rely on generic marketing, BGBx differentiates itself with a strong, multidisciplinary medical team and a clear focus on translating science into strategies that improve access and outcomes. The company’s goal is to help clients communicate complex science effectively while shaping reimbursement and market access to bring new therapies and devices to patients more efficiently.
Industries
Consulting
Healthcare
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
New York City, New York
Founded
2014
People at BGBx who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Hybrid Work Options
Professional Development Budget
BGB Group, a commercial solutions company for biopharmaceutical firms, has acquired Hayden Consulting Group, a market access and patient services consultancy. Financial terms were not disclosed. Hayden specialises in resolving complex payer, reimbursement and affordability challenges for global pharmaceutical brands. The acquisition combines Hayden's market access expertise with BGB's strategic advisory services, which span commercial due diligence, new product planning and go-to-market strategies. Hayden will continue to be led by co-founders Jamie Sidore and David MacDougall, becoming part of BGB's strategic advisory practice headed by Hilary Gentile. The combined entity aims to provide clients with integrated solutions across the full brand lifecycle, from early planning through commercialisation.
BGB Group appoints David Coman as Chief Executive Officer.
BGB Group recently hired Chris Palmer as its new chief creative officer, who joined from Havas Life New York.
Kuzel comes to imre from BGB Group, where she was EVP data, analytics and customer experience.
NEW YORK--(BUSINESS WIRE)--BGB Group (BGB), an award-winning healthcare commercialization and communications company headquartered in New York City with offices in Washington DC, Boston, and London, today announced a strategic partnership with Scrum50 (S50), a dynamic, agile-first creative agency based in South Norwalk, CT. This collaboration marks a transformative alliance, the next phase of BGB’s expertise enhancement aimed at remaining ahead of biopharma’s biggest challenges. The teams are set to redefine creativity and impact in the healthcare sector. S50 will continue to operate independently across all industry sectors. “We are excited to formalize our partnership with S50,” noted Greg Passaretti, Founding Partner of BGB Group. “We’ve been working together for nearly a year, and we realized that there’s much more that we can accomplish for a marketplace in need of broader creative and engagement solutions.”
Find jobs on Simplify and start your career today
Industries
Consulting
Healthcare
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
New York City, New York
Founded
2014
Find jobs on Simplify and start your career today